BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hafez Ghoran S, Calcaterra A, Abbasi M, Taktaz F, Nieselt K, Babaei E. Curcumin-Based Nanoformulations: A Promising Adjuvant towards Cancer Treatment. Molecules 2022;27:5236. [DOI: 10.3390/molecules27165236] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Laurindo LF, de Carvalho GM, de Oliveira Zanuso B, Figueira ME, Direito R, de Alvares Goulart R, Buglio DS, Barbalho SM. Curcumin-Based Nanomedicines in the Treatment of Inflammatory and Immunomodulated Diseases: An Evidence-Based Comprehensive Review. Pharmaceutics 2023;15. [PMID: 36678859 DOI: 10.3390/pharmaceutics15010229] [Reference Citation Analysis]
2 Li L, Jin P, Guan Y, Luo M, Wang Y, He B, Li B, He K, Cao J, Huang C, Li J, Shen Z. Exploiting Polyphenol-Mediated Redox Reorientation in Cancer Therapy. Pharmaceuticals (Basel) 2022;15. [PMID: 36558995 DOI: 10.3390/ph15121540] [Reference Citation Analysis]
3 Alhasawi MAI, Aatif M, Muteeb G, Alam MW, Oirdi ME, Farhan M. Curcumin and Its Derivatives Induce Apoptosis in Human Cancer Cells by Mobilizing and Redox Cycling Genomic Copper Ions. Molecules 2022;27:7410. [DOI: 10.3390/molecules27217410] [Reference Citation Analysis]